DHAX-R regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:R-DHAX; rituximab/dexamethasone/cytarabine/oxaliplatin
Overview
DHAX-R regimen refers to a regimen consisting of dexamethasone, High dose cytarabine (Ara-C), oxaliplatin ,rituximab, used to treat relapsed/refractory B-cell non-Hodgkin lymphoma[1]
Regimen
DDexamethasone
HHigh dose
Acytarabine (Ara-C)
xoxaliplatin
RRituximab
Indications
- Relapsed/refractory B-cell non-Hodgkin lymphoma[1]
References
- ↑ 1.0 1.1 Lignon J, Sibon D, Madelaine I, Brice P, Franchi P, Briere J; et al. (2010). “Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma”. Clin Lymphoma Myeloma Leuk. 10 (4): 262–9. doi:10.3816/CLML.2010.n.055. PMID 20709662.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH